Amiloride is neuroprotective in an MPTP model of Parkinson's disease
- 30 May 2008
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 31 (3) , 334-341
- https://doi.org/10.1016/j.nbd.2008.05.008
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Parkin-mediated Monoubiquitination of the PDZ Protein PICK1 Regulates the Activity of Acid-sensing Ion ChannelsMolecular Biology of the Cell, 2007
- Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemiaBrain, 2006
- Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug DiscoveryNeuron, 2006
- Acid-sensitive ionic channels in midbrain dopamine neurons are sensitive to ammonium, which may contribute to hyperammonemia damageProceedings of the National Academy of Sciences, 2006
- Calcium and pH homeostasis in neurons during hypoxia and ischemiaCell Calcium, 2004
- Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatumJournal of Neurochemistry, 2004
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neuronsNature Neuroscience, 2001
- Brain pHi, cerebral blood flow, and NADH fluorescence during severe incomplete global ischemia in rabbits.Stroke, 1993
- Amiloride and its analogs as tools in the study of ion transportThe Journal of Membrane Biology, 1988